Table 4.

Serum LDH and CK-MB in control (Group I), CEL per se (Group II), BPS (Group III), CEL + BPS (Group IV).

Group	LDH (IU/L)	CK-MB (IU/L)
I	78.30 ± 4.07	41.65 ± 2.87
II	107.47 ± 5.36*	66.17 ± 4.93**
III	74.16 ± 4.5	43.47 ± 2.90
IV	81.88 ± 4.32*	46.10 ± 2.77*

Values are expressed as mean ± SEM (n = 8) and analyzed by one-way ANOVA followed by Tukey-Kramer multiple comparison test.

^* p < 0.05 II v/s I, IV v/s II and

^** p < 0.01 II v/s I CEL: Celecoxib; BPS: Beraprost Sodium; LDH: lactate dehydrogenase; CK-MB: creatine kinase-MB.